The Department of Justice proposed reclassifying marijuana from a Schedule I to a Schedule III drug, aligning with Biden's directive for marijuana scheduling review.
Reclassifying marijuana acknowledges its medical uses and lower abuse potential, moving it away from being classified alongside heroin to a category with accepted medical substances like ketamine and testosterone.
Biden views the move as monumental in addressing inequality and reversing longstanding inequities. The process includes a 60-day public comment period and potential review by an Administrative Law Judge.
[
add
]
[
|
|
...
]